Having problems with message search?
The 2007 World Congress on Huntington's Disease was held in Dresden, Germany in September. I learned this morning on the HDAC forum that they have the entire 100 page PDF document available on their webiste! Go here: http://www.worldcongress-hd.net/html/2007/programme Click on WCHD 2007 Final Programme PDF Version on the left-hand side of the page. Or you can try this snip shortcut to the PDF document: http://snurl.com/1sbs5.
To enlarge the print, at the top of the Adobe browser you'll see the percent sign you're reading the document in, change that to 100%. If you're only interested in specific pages/topics and want to print those, go to those pages/topic then to "file" in the upper left-hand corner, to print, and put in the page numbers [from-to, ie 45-47] or just "current page" and hit print!
From the Index, it looks like it is chuck full of excellent reports many include the HD scientific research abstracts or studies we've shared or the HD Lighthouse has covered. Overall, an outstanding weekend!
Snips from the Index;
Plenary Session I: HD in Perspective: Looking Back and Looking Forward 24
Plenary Session II: Understanding the Biology of HD: Basic Mechanisms 24
Plenary Session III: Helping HD: Clinical Studies and Trials in HD 24
Scientific Session I: Pathogenesis and Pathophysiology of HD I 26
Clinical Session I: Understanding the Clinical Features of HD 28
IHA Session I: People with HD (Part I) 31
Scientific Session II: Pathogenesis and Pathophysiology of HD II 32
Clinical Session II: Biomarkers in HD 33
IHA Session II: People with HD (Part II) 37
Scientific Session III: Inflammatory and Metabolic Alterations in HD 37
Clinical Session III: Clinical Practice: Genetic Testing, Predicting Onset and Phenotype & Guidance for Care 40
IHA Session III: Young Peoples Views, Support Systems, Rehabilitation in Italy, Illness Perceptions 44
Scientific Session IV: Cell Replacement in HD 45
Clinical Session IV: Recent and Upcoming Clinical Studies/Trials in HD 46
IHA Session IV: Quality of Life in Patients with Huntington’s Disease 48
Scientific Session V: Experimental Models and HD Therapies in Experimental Models 49
Clinical Session V: HD Related Disorders: Neuroacanthocytosis & HDL2 50
IHA Session V: Challenge of Genetic Information 51
Scientific Session VI: Basic Science: Short Communications & Poster-Highlights 52
Clinical Session VI: Clinical Science: Short Communications & Poster-Highlights 53
IHA Session VI: Open Discussion 54
Plenary Session VII: Highlight Sessions 54
Poster Sessions Overview 55
Poster Presentations, ABSTR ACTS IN DET AIL 62
Basic Science 62
Pathogenesis 62
Huntington’s Disease Models - Characterisation 70
Experimental Therapy in Huntington’s Disease Model Systems 73
HD Restorative Approaches 77
Plenary Session II: Understanding the Biology of HD: Basic Mechanisms 24
Plenary Session III: Helping HD: Clinical Studies and Trials in HD 24
Scientific Session I: Pathogenesis and Pathophysiology of HD I 26
Clinical Session I: Understanding the Clinical Features of HD 28
IHA Session I: People with HD (Part I) 31
Scientific Session II: Pathogenesis and Pathophysiology of HD II 32
Clinical Session II: Biomarkers in HD 33
IHA Session II: People with HD (Part II) 37
Scientific Session III: Inflammatory and Metabolic Alterations in HD 37
Clinical Session III: Clinical Practice: Genetic Testing, Predicting Onset and Phenotype & Guidance for Care 40
IHA Session III: Young Peoples Views, Support Systems, Rehabilitation in Italy, Illness Perceptions 44
Scientific Session IV: Cell Replacement in HD 45
Clinical Session IV: Recent and Upcoming Clinical Studies/Trials in HD 46
IHA Session IV: Quality of Life in Patients with Huntington’s Disease 48
Scientific Session V: Experimental Models and HD Therapies in Experimental Models 49
Clinical Session V: HD Related Disorders: Neuroacanthocytosis & HDL2 50
IHA Session V: Challenge of Genetic Information 51
Scientific Session VI: Basic Science: Short Communications & Poster-Highlights 52
Clinical Session VI: Clinical Science: Short Communications & Poster-Highlights 53
IHA Session VI: Open Discussion 54
Plenary Session VII: Highlight Sessions 54
Poster Sessions Overview 55
Poster Presentations, ABSTR ACTS IN DET AIL 62
Basic Science 62
Pathogenesis 62
Huntington’s Disease Models - Characterisation 70
Experimental Therapy in Huntington’s Disease Model Systems 73
HD Restorative Approaches 77
CLINIC AL SCIENCE 81
History 81
Epidemiology 81
At Risk, Predictive and Diagnostic Testing 82
Predicting Age of Onset and Phenotype 87
Clinical Phenotype – Motor and Motor Assessment 90
Clinical Phenotype – Cognition and Cognitive Assessment 98
Clinical Phenotype – Psychopathology and Behaviour 104
Clinical Phenotype - Miscellaneous 109
Clinical Phenotype - Juvenile Huntington’s Disease 113
Biomarkers of Huntington’s Disease - Imaging 115
Biomarkers of Huntington’s Disease - Body Fluids 122
Treatment of Huntington’s Disease - Clinical Studies 126
Care of Huntington’s Disease Patients 130
History 81
Epidemiology 81
At Risk, Predictive and Diagnostic Testing 82
Predicting Age of Onset and Phenotype 87
Clinical Phenotype – Motor and Motor Assessment 90
Clinical Phenotype – Cognition and Cognitive Assessment 98
Clinical Phenotype – Psychopathology and Behaviour 104
Clinical Phenotype - Miscellaneous 109
Clinical Phenotype - Juvenile Huntington’s Disease 113
Biomarkers of Huntington’s Disease - Imaging 115
Biomarkers of Huntington’s Disease - Body Fluids 122
Treatment of Huntington’s Disease - Clinical Studies 126
Care of Huntington’s Disease Patients 130
Offline 
Send Email